Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Share this content:

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Sponsors and Collaborators
Ferring Pharmaceuticals

Contact
Clinical Development Support
DK0-Disclosure@ferring.com

Principal Investigator
Clinical Development Support, Ferring Pharmaceuticals

ClinicalTrials.gov Identifier
NCT01729676

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters